Related Experiment Video
Updated: Nov 16, 2025

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
A Quality Improvement Initiative Targeting Chronic Kidney Disease Metrics Through Increased Urinary Albumin Testing
Ken J Park1, Robert S Unitan2, Micah L Thorp1
1Department of Nephrology, Kaiser Permanente Northwest, Portland, OR.
Insights
Automated urine albumin testing (ACR) in chronic kidney disease (CKD) patients increased significantly. However, this did not improve medication use (ACEi/ARB) or other CKD quality metrics, indicating a need for different interventions.
Area of Science:
- Nephrology
- Health Informatics
- Quality Improvement
Background:
- Chronic kidney disease (CKD) quality metrics, including urinary albumin testing and ACEi/ARB use, were lower in Kaiser Permanente Northwest.
- Improving these metrics is crucial for effective CKD management.
Purpose of the Study:
- To evaluate if increased urine albumin-to-creatinine ratio (ACR) testing improves CKD quality metrics.
- To assess the impact of automated ACR testing linked to EHR alerts on ACEi/ARB initiation.
Main Methods:
- A quality improvement project automated ACR testing for stage 3 CKD patients.
- An informatics tool linked EHR alerts to recommend ACEi/ARB for renal indications.
Main Results:
- ACR testing rates increased from 26.9% to over 80% post-implementation (p < 0.001).
- No significant increase in ACEi or ARB use was observed (65.8% vs. 66.4%, p = 0.54).
- Other quality metrics, including diabetes and hypertension control, also showed no significant change.
Conclusions:
- Automated ACR testing linked with EHR alerts did not improve CKD quality metrics in stage 3 CKD patients.
- Further strategies are needed to enhance the use of guideline-recommended therapies in CKD care.
Introduction:
Achievement of quality metrics in chronic kidney disease (CKD), specifically urinary albumin testing and angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) use, remained lower in Kaiser Permanente Northwest compared with other Kaiser Permanente regions. We were interested if more frequent testing of urine albumin (ACR) improved CKD quality metrics.
Methods:
We implemented a quality improvement project automating ACR testing using an informatics tool in patients with stage 3 CKD linked to an electronic health record (EHR) alert recommending ACEi or ARB initiation in patients with renal indication.
Results:
At 1 and 2 years after implementation of ACR testing, ACR testing increased from 26.9% prior to implementation to 83% at 1 year and 77% at 2 year after implementation (p < 0.001). However, ACEi or ARB use did not increase significantly (65.8% vs 65.7% vs 66.4%, p = 0.54). There was also no significant change in other quality metrics, including diabetes control, hypertension control, and comanagement of higher-risk CKD patients.
Discussion And Conclusion:
In patients with stage 3 CKD, increased ACR testing via automated testing linked with EHR alert did not result in an improvement in CKD quality metrics.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease I: Introduction
Nephrotic Syndrome II : Assessment and Medical Management

